- Airline and cruise stocks fell on Monday after a new COVID-19 strain identified in the UK led to a wave of more stringent lockdowns and travel restrictions in the area.
- It’s not yet known if the new COVID-19 strain, which has a higher transmission rate, is impacted by the vaccines developed by Pfizer and Moderna.
- Shares of Delta Air Lines fell as much as 9% on Monday, while Carnival Corporation dropped as much as 12%.
- Visit Business Insider’s homepage for more stories.
Travel-related stocks plunged on Monday as a new COVID-19 strain identified in the UK put a dent in investor optimism around an economic reopening.
Surging virus cases and concerns around the new mutation has led to a string of new lockdowns and travel restrictions in the UK. A Tier 4 lockdown hit London on Sunday, which bars people from gathering with other people outside of their households.
Airline stocks plunged. Delta Air Lines fell as much as 9%, while America Airlines and Jet Blue fell as much as 9% and 7%, respectively.
Cruise stocks also took a sizable hit in Monday trades. Carnival Corporation led the decline, down as much as 12%, while Norwegian Cruise Line Holdings and Royal Caribbean fell as much as 11% and 10%, respectively.
Video: Stocks move higher at open on vaccine hopes (CNBC)
Markets 'under-handicapping' risk of no-deal Brexit, fund manager says
CNBC
Mnuchin: Direct payments to qualifying Americans could hit bank accounts soon
CNBC
Epidemiologist on new Covid strain in the United Kingdom
CNBC
Sen. Pat Toomey on Congress' agreement on $900 billion Covid relief package
CNBC
Purdue University president on keeping tuition costs flat during the pandemic
CNBC
The Pre-Market Rundown 2: December 21, 2020
CNBC
CDC recommends frontline workers, seniors 75+ should be next in line for vaccine
CNBC
Former FDA chief Gottlieb on new Covid strain: Eventually will have to update vaccines
CNBC
Tesla shares are more volatile than most S&P 500 stocks
CNBC
Why this portfolio manager isn't changing strategies in light of new Covid strain
CNBC
Hackensack Meridien Health CEO on the rollout of Moderna's COVID-19 vaccine
CNBC
Here's what's in the $900 billion Covid relief deal
CNBC
Shippers prepare to move both Pfizer and Moderna vaccines simultaneously
CNBC
Tesla's S&P 500 addition will lead to higher scrutiny: GLJ Research CEO
CNBC
Top market watchers on how to model the risk of a new coronavirus strain in Europe
CNBC
BNY Mellon: New virus restrictions in Europe could impact markets into the end of the year
CNBC
Markets 'under-handicapping' risk of no-deal Brexit, fund manager says
James Athey, senior investment manager at Aberdeen Standard Investments, discusses the impact of Brexit uncertainty on markets.
CNBC
Mnuchin: Direct payments to qualifying Americans could hit bank accounts soon
"The good news is this is a very, very fast way of getting money into the economy. Let me emphasize. People are going to see this money at the beginning of next week," Treasury Secretary Steven Mnuchin told CNBC's Jim Cramer. "So, it's very fast. Its money that gets recirculated in the company," said Mnuchin.
CNBC
Epidemiologist on new Covid strain in the United Kingdom
Dr. David Levy is an epidemiologist and CEO of EHE Health, a national health-care provider to big companies like BNP Paribas, IBM and Lockheed Martin. Dr. Levy joined "Squawk Box" on Monday to discuss the new strain of Covid-19 in the United Kingdom as well as some of the best practices for fighting the virus.
CNBC
Read more: BANK OF AMERICA: Buy these 26 cheap and fundamentally rock-solid stocks before the economic rebound sends them soaring in 2021
The mutated COVID-19 strain that has been identified in the UK is thought to be able to spread more quickly than the original strain, according to the UK’s chief medical officer Chris Whitty.
But there is no evidence yet that the strain is more deadly or will affect vaccines and treatments, “although urgent work is underway to confirm this,” Whitty said.
Fear that another variant of COVID-19 that might throw a wrench in plans to swiftly reach herd immunity and squash the virus via hundreds of millions of vaccines from Pfizer, Moderna and others has stocks reeling on Monday.
Read more: A hedge fund chief who oversees $2 billion breaks down why we’re in for a 61% stock-market crash over the next 18-24 months – and shares 3 types of companies he’s shorting right now
Source: Read Full Article